Similar to adult GBM, a study found that inhibition of HDAC/PI3K via dual inhibitor, CUDC-907, in pediatric HGG models exerts substantial antitumor effects compared to single-target inhibition [84]. The gene discussed is PIK3CA; the disease is glioblastoma.